US drink giant PepsiCo has lodged an appeal of a court win for the Australian Taxation Office over payments made by Schweppes under a distribution agreement that were found to be subject to royalty withholding tax.
International law firm HFW has lured a team of eight lawyers from Clyde & Co, led by a partner known for his litigation funding practice.
Gaming giant Aristocrat is suing its head of design for alleged intellectual property infringement and has secured orders restraining him from using or disclosing any of thousands of company files he is accused of copying.
A month after a UK tribunal ruled Sony Group must face a class action on behalf of millions of consumers, the game giant has been hit with a class action in Australia accusing the Japanese company of restrictive trade practices.
A $27.5 million settlement reached in a class action over the alleged unlawful detention of 240 Indonesian children has won court approval, but the applicant’s legal costs remain subject to negotiations.
Worley contravened the Corporations Act a decade ago when it failed to correct 2014 earnings guidance for several months, but shareholders in a long-running class action against the engineering services company have failed to prove the breach caused any loss, a judge has found.
The percentage of senior women barristers who were briefed on cases in the past financial year dropped from the previous year, according to the latest report on the peak legal body’s equitable briefing initiative. The proportion of all counsel fees going to women also took a slide, the Law Council of Australia said.
The funders that bankrolled a securities class action against collapsed engineering firm RCR Tomlinson will ask the court to give them an $8 million cut of a $40 million settlement. A further $12 million in legal fees means shareholders will get 50 per cent of the settlement sum.
A judge has signed off on a class action settlement under which the Commonwealth Bank of Australia will pay a sum towards the applicant’s costs but group members will recover nothing.
Despite proposing a divestiture as part of its planned takeover of Healius, Australian Clinical Labs has failed to win the approval of the competition regulator for the $1.5 billion deal.